160 related articles for article (PubMed ID: 1860268)
21. Cyclosporin A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
Brodehl J; Brandis M; Helmchen U; Hoyer PF; Burghard R; Ehrich JH; Zimmerhackl RB; Klein W; Wonigeit K
Klin Wochenschr; 1988 Nov; 66(22):1126-37. PubMed ID: 3236762
[TBL] [Abstract][Full Text] [Related]
22. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
[TBL] [Abstract][Full Text] [Related]
23. [Cyclosporine in the treatment of primary focal-segmental glomerulosclerosis].
Pavlović S; Djukanović Lj; Sindjić M; Stojković D; Banković-Calić N; Velimirović D
Srp Arh Celok Lek; 1996; 124 Suppl 1():51-3. PubMed ID: 9102929
[TBL] [Abstract][Full Text] [Related]
24. Comparison between pre- and posttreatment renal biopsies in children receiving ciclosporine for idiopathic nephrosis.
Habib R; Niaudet P
Clin Nephrol; 1994 Sep; 42(3):141-6. PubMed ID: 7994931
[TBL] [Abstract][Full Text] [Related]
25. Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults.
Ponticelli C; Passerini P
Clin Nephrol; 1991; 35 Suppl 1():S16-21. PubMed ID: 1860261
[TBL] [Abstract][Full Text] [Related]
26. Treatment of idiopathic nephrotic syndrome with cyclosporin A in children.
Hamed RM
J Nephrol; 1997; 10(5):266-70. PubMed ID: 9364319
[TBL] [Abstract][Full Text] [Related]
27. The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study.
Banfi G; Moriggi M; Sabadini E; Fellin G; D'Amico G; Ponticelli C
Clin Nephrol; 1991 Aug; 36(2):53-9. PubMed ID: 1934660
[TBL] [Abstract][Full Text] [Related]
28. Pharmacologic management of adult idiopathic nephrotic syndrome.
Alaniz C; Brosius FC; Palmieri J
Clin Pharm; 1993 Jun; 12(6):429-39. PubMed ID: 8403814
[TBL] [Abstract][Full Text] [Related]
29. Normal renal function 8 to 13 years after cyclosporin A therapy in 285 diabetic patients.
Assan R; Blanchet F; Feutren G; Timsit J; Larger E; Boitard C; Amiel C; Bach JF
Diabetes Metab Res Rev; 2002; 18(6):464-72. PubMed ID: 12469360
[TBL] [Abstract][Full Text] [Related]
30. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports.
Fencl F; Simková E; Vondrák K; Janda J; Chadimová M; Stejskal J; Seeman T
Transplant Proc; 2007 Dec; 39(10):3488-90. PubMed ID: 18089416
[TBL] [Abstract][Full Text] [Related]
31. Relapse of nephrotic syndrome following remission for 20 years.
Cuoghi D; Vangelista A; Baraldi A; Cheli E
Int J Pediatr Nephrol; 1983 Sep; 4(3):211-4. PubMed ID: 6315615
[TBL] [Abstract][Full Text] [Related]
32. Histopathological diagnosis and outcome of paediatric nephrotic syndrome.
Ejaz I; Khan HI; Javaid BK; Rasool G; Bhatti MT
J Coll Physicians Surg Pak; 2004 Apr; 14(4):229-33. PubMed ID: 15228828
[TBL] [Abstract][Full Text] [Related]
33. Idiopathic focal segmental glomerulosclerosis: a favourable prognosis in untreated patients?
Deegens JK; Assmann KJ; Steenbergen EJ; Hilbrands LB; Gerlag PG; Jansen JL; Wetzels JF
Neth J Med; 2005 Nov; 63(10):393-8. PubMed ID: 16301760
[TBL] [Abstract][Full Text] [Related]
34. [Nephrotic syndrom with focal and segmental glomerulosclerosis in Dakar: epidemiological and clinicopathological characteristics (about 134 cases)].
Niang A; Dial C; Ka EF; Lèye A; Pouye A; Ka MM; Mbengue M; Droz D; Diouf B
Dakar Med; 2008; 53(1):45-51. PubMed ID: 19102117
[TBL] [Abstract][Full Text] [Related]
35. Duration of optimal therapy for idiopathic focal segmental glomerulosclerosis.
Pokhariyal S; Gulati S; Prasad N; Sharma RK; Singh U; Gupta RK; Mittal S; Mehta B
J Nephrol; 2003; 16(5):691-6. PubMed ID: 14733415
[TBL] [Abstract][Full Text] [Related]
36. Long-term clinical and pathological effects of cyclosporin in children with nephrosis.
Seikaly MG; Prashner H; Nolde-Hurlbert B; Browne R
Pediatr Nephrol; 2000 Mar; 14(3):214-7. PubMed ID: 10752760
[TBL] [Abstract][Full Text] [Related]
37. Long-term benefits and risks of cyclosporin A (sandimmun)--an analysis at 10 years.
Thiel G; Bock A; Spöndlin M; Brunner FP; Mihatsch M; Rufli T; Landmann J
Transplant Proc; 1994 Oct; 26(5):2493-8. PubMed ID: 7940765
[TBL] [Abstract][Full Text] [Related]
38. Cyclosporin therapy for steroid resistant nephrotic focal glomerulosclerosis.
Windom HH; Fisher M; Neale TJ
N Z Med J; 1990 Mar; 103(886):125-6. PubMed ID: 2320338
[TBL] [Abstract][Full Text] [Related]
39. [Lipoid nephrosis in childhood].
Niaudet P
Rev Prat; 2003 Nov; 53(18):2027-32. PubMed ID: 15008217
[TBL] [Abstract][Full Text] [Related]
40. Predictive factors for ciclosporin-associated nephrotoxicity in children with minimal change nephrotic syndrome.
Kim JH; Park SJ; Yoon SJ; Lim BJ; Jeong HJ; Lee JS; Kim PK; Shin JI
J Clin Pathol; 2011 Jun; 64(6):516-9. PubMed ID: 21441261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
